CORNEAL ENDOTHELIAL PERMEABILITY AFTER SILICONE OIL EXPOSURE - ROLE OF LOW-MOLECULAR-WEIGHT COMPONENTS AND CATALYST

被引:4
|
作者
GREEN, K
CHEEKS, L
SLAGLE, T
STEWART, DA
TRASK, DK
机构
[1] MED COLL GEORGIA,DEPT PHYSIOL & ENDOCRINOL,AUGUSTA,GA 30912
[2] RICHARD JAMES INC,PEABODY,MA
[3] DARTMOUTH COLL,HANOVER,NH 03756
来源
JOURNAL OF TOXICOLOGY-CUTANEOUS AND OCULAR TOXICOLOGY | 1993年 / 12卷 / 04期
关键词
D O I
10.3109/15569529309050148
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Silicone oils induce corneal and retinal pathologic changes by undefined mechanisms that may relate to certain components. Low-molecular-weight components have often been postulated to cause these ocular toxicities. Several types of additives that occur as contaminants or by-products in crude silicone oils were tested for their effects on rabbit corneal endothelial permeability. A purified oil plus various additives was perfused to fill about 75% of anesthetized rabbit anterior chambers. In vitro endothelial permeabilities to inulin and dextran were determined after 1 week. A long-chain silanol-terminated polydimethylsiloxane (viscosity, 1000 cps) at 2 mg/ml, a catalyst (tetramethylammonium siloxamplate) at l mg/ml, and a mixture of a series of linear compounds (hexamethyldisiloxane [MM] through hexacosamethyldodecasiloxane [MD(10)M]) each at 10 mg/ml, resulting in the largest permeability increase. A mixture of two short-chain silanol-terminated compounds (15-35 cps plus 80 cps, each at 1 mg/ml) was less damaging, while the cyclic series gave ambiguous results. One series of hexamethylcyclotrisiloxane (D3), octamethylcyclotetrasiloxane (D4), and decamethylcyclopentasiloxane (D5) produced a modest increase in permeability, while another identical series from a different supplier had no effect and a mixture of a long series of various cyclic compounds from D3-D21 was without effect. Certain compounds have greater potential to induce toxic effects on the corneal endothelium including a linear series, a silanol-terminated polydimethylsiloxane, and a catalyst. Toxicity could reside in relatively few compounds; of these the linear series and the catalyst have been identified in silicone oils.
引用
收藏
页码:313 / 321
页数:9
相关论文
共 50 条
  • [41] Portable Compression Device and Low-Molecular-Weight Heparin Compared With Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Joint Arthroplasty
    Edwards, John Z.
    Pulido, Pamela A.
    Ezzet, Kace A.
    Copp, Steven N.
    Walker, Richard H.
    Colwell, Clifford W., Jr.
    JOURNAL OF ARTHROPLASTY, 2008, 23 (08) : 1122 - 1127
  • [42] Low-molecular-weight organogelators as functional materials for oil spill remediation
    Ohsedo, Yutaka
    POLYMERS FOR ADVANCED TECHNOLOGIES, 2016, 27 (06) : 704 - 711
  • [43] Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin
    Turpie, AGG
    Norris, TM
    THROMBOSIS AND HAEMOSTASIS, 2004, 92 (01) : 3 - 12
  • [44] Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture
    O'Toole, Robert V.
    Stein, Deborah M.
    O'Hara, Nathan N.
    Frey, Katherine P.
    Taylor, Tara J.
    Scharf-stein, Daniel O.
    Carlini, Anthony R.
    Sudini, Kuladeep
    Degani, Yasmin
    Slobogean, Gerard P.
    Haut, Elliott R.
    Obremskey, Wil-liam
    Firoozabadi, Reza
    Bosse, Michael J.
    Goldhaber, Samuel Z.
    Marvel, Debra
    Castillo, Renan C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (03) : 203 - 213
  • [45] Leukocytoclasic vasculitis after injection of low-molecular-weight heparin
    de Bats, B
    Rivard, L
    Bellemin, B
    Duflo, F
    Allaouchiche, B
    Chassard, D
    PRESSE MEDICALE, 2000, 29 (29): : 1604 - 1604
  • [46] Low-molecular-weight heparin thromboprophylaxis in pregnancy - The role of monitoring
    Shiach, CR
    Johnston, TA
    Johnston, E
    THROMBOSIS RESEARCH, 2005, 115 : 142 - 142
  • [47] The emerging role of low-molecular-weight heparin in cardiovascular medicine
    Hirsh, J
    Bates, SM
    PROGRESS IN CARDIOVASCULAR DISEASES, 2000, 42 (04) : 235 - 246
  • [48] The Safety of Low-Molecular-Weight Heparin During and After Pregnancy
    Lu, Eric
    Shatzel, Joseph J.
    Salati, Jennifer
    DeLoughery, Thomas G.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2017, 72 (12) : 721 - 729
  • [49] REMOVAL OF LOW-MOLECULAR-WEIGHT COMPONENTS DURING THERMAL DEBINDING OF POWDER COMPACTS
    ANGERMANN, HH
    YANG, FK
    VANDERBIEST, O
    JOURNAL OF MATERIALS SCIENCE, 1992, 27 (09) : 2534 - 2538
  • [50] Low-molecular-weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells
    Zemani, F
    Benisvy, D
    Galy-Fauroux, I
    Lokajczyk, A
    Colliec-Jouault, S
    Uzan, G
    Fischer, AM
    Boisson-Vidal, C
    BIOCHEMICAL PHARMACOLOGY, 2005, 70 (08) : 1167 - 1175